Home › Markets › Health Care › TMDX

TransMedics Group Inc. (TMDX)

TMDX trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$79.14
+1.23% on the day
Market cap
$2.7B
Mid cap
Revenue · 2025
$605.5M
+37.1% on 2024
Net income · 2025
$190.3M
31.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerTMDX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2019
SEC CIK0001756262
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inMA

Financials · 2025

LineValue
Revenue$605.5M
Net income$190.3M
Operating income$108.6M
Net margin31.4%
Operating margin17.9%
Revenue growth+37.1%
CashNot in SEC XBRL data
Total assets$1.1B
P/E (computed)14.4×
P/S (computed)4.5×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52022-08-05
Latest annual report10-K2026-02-24
Latest quarterly / interim10-Q2026-08-04
Latest current report8-K2026-09-10
Latest proxyDEFA14A2026-05-07

Source: SEC EDGAR submissions feed, 627 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-6.7%
1 month-14.1%
3 months-0.5%
Year to date-37.8%
1 year-32.3%
From 52-week high-49.7%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
AXGNAxogen Inc.$36.17-2.53%$2.1B
LIVNLivaNova PLC$76.37-1.17%$4.2B
ITGRInteger Holdings Corporation$126.59+0.06%$4.3B
CNMDCONMED Corporation$45.55+0.42%$1.4B
CBLLCeriBell Inc.$26.14+3.48%$1.0B
INMDInMode Ltd.$14.30+0.04%$822.3M
CVCapsoVision Inc.$6.78+0.30%$360.7M
ELMDElectromed Inc.$27.68-1.53%$229.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier